Last reviewed · How we verify
NCT07057817: ACHILLS
The ACHILLS Trial; Application of Cerament in Heel Infection for Lower Limb Salvage
NA trial testing Cerament G in Osteomyelitis in 30 participants. Not yet recruiting.
25 July 2026
Quick facts
| Lead sponsor | Royal College of Surgeons, Ireland |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 25 July 2025 |
| Primary completion | 25 July 2026 |
| Estimated completion | 25 July 2026 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Cerament G
- Standard Surgical Managment
Conditions studied
- Osteomyelitis — all drugs for Osteomyelitis →
- Diabetes — all drugs for Diabetes →
- Calcanectomy — all drugs for Calcanectomy →
Sponsor
Royal College of Surgeons, Ireland
Who can join
18 and older, any sex, with Osteomyelitis or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The ACHILLS Trial is a multicentre randomised controlled feasibility study comparing partial calcanectomy with and without the use of an antibiotic-impregnated bone graft substitute (Cerament G) for treating calcaneal osteomyelitis, specifically on wound healing rates, re-infection, and overall efficacy in a sample of 30 patients over a one-year period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07057817
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteomyelitis
Currently open trials in the same condition.
- NCT06283979 — A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Assoc · Phase 2 · recruiting
- NCT07056881 — Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa · recruiting
- NCT06526884 — Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) · NA · active not recruiting
- NCT05713149 — Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents · recruiting
- NCT03594344 — Additional Hyperbaric Oxygen After Lower Extremity Amputation · NA · recruiting
Other Royal College of Surgeons, Ireland trials
Trials by the same sponsor.
- NCT07443579 — Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography · NA · recruiting
- NCT07426861 — Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence · NA · recruiting
- NCT07426835 — The PHARO Trial: The Incidence of Para-conduit Hernia With Closure of Hiatus Versus the Standard Approach in Robotic Oes · NA · recruiting
- NCT07426809 — Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). · NA · recruiting
- NCT07426848 — OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07057817 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royal College of Surgeons, Ireland
- Last refreshed: 3 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07057817.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing